Product Details
Place of Origin: china
Brand Name: Ceftriaxone Sodium for injection 1G/0.5G Ceftriaxone Sodique for injection
Certification: GMP
Model Number: 74578-69-1
Payment & Shipping Terms
Minimum Order Quantity: 100000 Vials
Delivery Time: 55 days
Payment Terms: TT; LC
Side Effects: |
May Cause Allergic Reactions, Nausea, And Dizziness |
Prescription Status: |
Prescription Only |
Factory: |
BBCA Pharma |
Pharmaceutical Way: |
Chemical Synthesis |
Standard: |
BP |
Dosage: |
IV/IM |
Form: |
White Crystalline Or Crystalline Powder |
Place: |
ANHUI |
Side Effects: |
May Cause Allergic Reactions, Nausea, And Dizziness |
Prescription Status: |
Prescription Only |
Factory: |
BBCA Pharma |
Pharmaceutical Way: |
Chemical Synthesis |
Standard: |
BP |
Dosage: |
IV/IM |
Form: |
White Crystalline Or Crystalline Powder |
Place: |
ANHUI |
The Powder for Injection is a pharmaceutical product developed through a precise chemical synthesis process, ensuring high purity and efficacy. This product is designed for administration via both intramuscular (IM) and intravenous (IV) routes, making it versatile for various clinical applications. The powder form allows for easy reconstitution and administration, providing healthcare professionals with a reliable option for treating patients requiring injectable medication.
Available in convenient package sizes, the Powder for Injection comes in boxes containing either 10 vials or 50 vials, catering to different usage needs from individual treatments to larger clinical settings. Each vial contains either 1 gram or 0.5 grams of the active pharmaceutical ingredient in powder form, allowing for flexible dosing based on the specific requirements of the patient and the prescribing healthcare provider.
The Powder for Injection is intended for use in both IM and IV administrations. Intramuscular injections facilitate the absorption of the medication into the bloodstream through muscle tissue, while intravenous injections allow for direct delivery into the bloodstream, ensuring rapid onset of action. This dual administration route enhances the utility of the product across a range of medical conditions where injectable therapy is indicated.
Despite its therapeutic benefits, users of the Powder for Injection should be aware of potential side effects that may occur. Some patients might experience allergic reactions, which could manifest as rash, itching, swelling, or more severe hypersensitivity responses. Additionally, common side effects such as nausea and dizziness have been reported. It is vital for healthcare providers to monitor patients closely after administration, particularly during the initial doses, to manage and mitigate any adverse reactions promptly.
The chemical synthesis method utilized in producing the Powder for Injection ensures that the medication meets stringent quality standards. This process allows for the consistent manufacture of a stable and effective product, suitable for clinical use. The powder form also contributes to an extended shelf life and ease of storage, which are critical factors in pharmaceutical logistics and patient care.
Healthcare professionals appreciate the Powder for Injection for its ease of handling and precise dosing capabilities. The availability of 1g and 0.5g powder strengths provides flexibility in treatment protocols, allowing for accurate adjustment of doses tailored to individual patient needs. This adaptability is particularly important in settings where dosage must be carefully managed, such as in pediatric or geriatric populations.
In summary, the Powder for Injection is a well-formulated injectable medication produced by chemical synthesis, available in multiple package sizes and dosages. Its administration via IM and IV routes makes it a valuable therapeutic option across various clinical scenarios. While its use is generally safe and effective, attention to potential side effects like allergic reactions, nausea, and dizziness is essential. The product's design, packaging, and delivery routes collectively ensure that it meets the diverse needs of healthcare providers and patients alike.
The Powder for Injection of Ceftriaxone Sodium for injection 1G/0.5G, also known as Ceftriaxone Sodique for injection, is a high-quality pharmaceutical product manufactured by BBCA Pharma in China. With the model number 74578-69-1, this white crystalline or crystalline powder is certified under GMP standards, ensuring its safety and efficacy for medical use. The product is available in package sizes of 10 vials or 50 vials per box, catering to various healthcare facility requirements. It is designed specifically for intramuscular (IM) and intravenous (IV) administration, providing versatile application options in clinical settings.
The Powder for Injection is widely used in hospitals, clinics, and healthcare centers for the treatment of bacterial infections. Due to its broad-spectrum antibiotic properties, it is especially effective in managing respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. The flexibility of IM/IV administration makes it suitable for patients requiring quick absorption and immediate therapeutic effects. This feature is particularly beneficial in emergency situations where rapid intervention is critical.
Healthcare professionals prefer Ceftriaxone Sodium powder for injection for its ease of preparation and reliable potency. It is reconstituted into a solution before being administered via IM or IV routes, allowing for precise dosing tailored to individual patient needs. The product's crystalline form ensures stability and long shelf life, which is essential for maintaining drug efficacy during storage and transportation. With a minimum order quantity of 100,000 vials and delivery time of approximately 55 days, BBCA Pharma supports large-scale procurement to meet the demands of hospitals and distributors worldwide.
Additionally, OEM services are available, enabling customization of packaging and labeling to align with the branding requirements of different markets. Payment terms such as TT and LC provide flexibility for international buyers. Originating from China, this Powder for Injection meets stringent regulatory standards, making it a reliable choice for healthcare providers seeking effective antibiotic treatments via IM/IV administration.
In summary, Ceftriaxone Sodium for injection 1G/0.5G Powder for Injection by BBCA Pharma is an indispensable pharmaceutical product for combating bacterial infections through IM/IV routes. Its certified quality, versatile application scenarios, and scalable production capacity make it an ideal option for medical institutions aiming to deliver high-standard patient care.
Our Powder for Injection product, branded as Ceftriaxone Sodium for injection 1G/0.5G Ceftriaxone Sodique for injection, is manufactured by BBCA Pharma in China with GMP certification, ensuring the highest quality standards for medical grade powder for injection.
The product model number is 74578-69-1 and is available in powder forms of 1G and 0.5G, presented as white crystalline or crystalline powder. It is ideal for use as Ampicillin sodium for injection and other similar applications.
We offer a minimum order quantity of 100,000 vials, with a delivery time of 55 days. Payment terms include TT and LC, providing flexible options for our customers.
For optimal preservation, the powder for injection should be stored at room temperature, maintaining its efficacy and stability.
Our Powder For Injection product is supported by a dedicated technical team committed to ensuring optimal performance and customer satisfaction. We provide comprehensive product documentation, including detailed usage guidelines, safety data sheets, and storage instructions to assist healthcare professionals in the correct handling and administration of the product.
Technical support is available to address any inquiries regarding product formulation, compatibility, and application methods. Our experts are equipped to offer guidance on best practices for reconstitution and administration to maximize efficacy and patient safety.
We also offer training sessions and workshops for healthcare providers to enhance their understanding and proficiency in using the Powder For Injection product effectively. These sessions cover topics such as preparation techniques, dosage calculations, and troubleshooting common issues.
In addition, we provide after-sales services including product stability monitoring and assistance with regulatory compliance to ensure ongoing quality and adherence to healthcare standards.
Our commitment to service excellence ensures that users of the Powder For Injection product receive timely and accurate support throughout the product lifecycle.